Gara Jalqabaatti › Dukkana Dhiigaa › Distaarikii Koloombiyaa › Washington
Qorannoo klinikaalii Dukkana Dhiigaa Washington, DC keessatti
Qorannoo 19 Dukkana Dhiigaa f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · Miili 7 fagaatti
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Longitudinal Studies of Patient With FPDMM
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
Namoota walitti qabaa jira
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · Miili 7 fagaatti
- Nih/Nhlbi, Bethesda · Miili 7 fagaatti
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · Miili 7 fagaatti
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Namoota walitti qabaa jiraQorannoo ilaalaa
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · Miili 7 fagaatti
Qorannoo Dukkana Dhiigaa magaalota biroo keessatti
- Houston, TXQorannoo 46
- New York City, NYQorannoo 26
- Boston, MAQorannoo 25
- Seattle, WAQorannoo 18
- Baltimore, MDQorannoo 18
- Los Angeles, CAQorannoo 17
- Durham, NCQorannoo 16
- Chicago, ILQorannoo 15
- Philadelphia, PAQorannoo 14
- Columbus, OHQorannoo 13
- Edison, NJQorannoo 13
- Nashville, TNQorannoo 13
Qorannoo biroo Washington keessatti
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 55
- Saree OljooQorannoo 46
- Kansara MetastatikiiQorannoo 43
- Dhibee QaraQorannoo 41
- Kansarii ProstateQorannoo 38
- ObesityQorannoo 33
- Kansarii ColorectalQorannoo 29
- Dhibee Onneessaa fi DhiigaQorannoo 28
- Dukkana BladderQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 24
- Kansarii OvariiQorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.